scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1008217116 |
P356 | DOI | 10.1007/S00253-016-7705-3 |
P698 | PubMed publication ID | 27412463 |
P50 | author | Dipesh Dhakal | Q57555503 |
Tokutaro Yamaguchi | Q61145386 | ||
Anaya Raj Pokhrel | Q89532099 | ||
Hye Jin Jung | Q92334205 | ||
Jae Kyung Sohng | Q57555493 | ||
P2093 | author name string | Byung-Gee Kim | |
Prakash Parajuli | |||
Anil Shrestha | |||
Amit Kumar Chaudhary | |||
Seung-Young Kim | |||
Jeong Sang Yi | |||
Biplav Shrestha | |||
P2860 | cites work | Enzymatic assembly of DNA molecules up to several hundred kilobases | Q28241142 |
Use of Dinitrosalicylic Acid Reagent for Determination of Reducing Sugar | Q29305147 | ||
Natural products as sources of new drugs over the 30 years from 1981 to 2010 | Q29616640 | ||
Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. | Q33227202 | ||
BglBricks: A flexible standard for biological part assembly | Q33657298 | ||
The re-emergence of natural products for drug discovery in the genomics era. | Q34459318 | ||
Production, isolation and biological activity of nargenicin from Nocardia sp. CS682. | Q34867855 | ||
Nargenicin enhances 1,25-dihydroxyvitamin D(3)- and all-trans retinoic acid-induced leukemia cell differentiation via PKCbetaI/MAPK pathways | Q34980103 | ||
DNA assembler: a synthetic biology tool for characterizing and engineering natural product gene clusters | Q35064599 | ||
Improvement of antibiotic activity of Xenorhabdus bovienii by medium optimization using response surface methodology | Q35582878 | ||
Commentary: Toward a new focus in antibiotic and drug discovery from the Streptomyces arsenal | Q35856285 | ||
De novo biosynthetic pathways: rational design of microbial chemical factories | Q37251461 | ||
Response surface methodology (RSM) as a tool for optimization in analytical chemistry | Q37257532 | ||
Metabolic engineering of microorganisms: general strategies and drug production | Q37262445 | ||
Construction and optimization of synthetic pathways in metabolic engineering | Q37706740 | ||
Molecular insights on the biosynthesis of antitumour compounds by actinomycetes | Q37845949 | ||
Synthetic biology and the development of tools for metabolic engineering | Q37982199 | ||
Elucidation of DnaE as the Antibacterial Target of the Natural Product, Nargenicin | Q38411940 | ||
Genetic Manipulation of Nocardia Species. | Q38417455 | ||
Laboratory Maintenance of Nocardia Species. | Q38420831 | ||
Herboxidiene biosynthesis, production, and structural modifications: prospect for hybrids with related polyketide | Q38423236 | ||
Structural modification of herboxidiene by substrate-flexible cytochrome P450 and glycosyltransferase. | Q38428716 | ||
Enhanced production of nargenicin A(1) and generation of novel glycosylated derivatives. | Q38429805 | ||
Biosynthesis of the nargenicin A1 pyrrole moiety from Nocardia sp. CS682. | Q38470350 | ||
Metabolic engineering of natural product biosynthesis in actinobacteria | Q38801966 | ||
Functional expression of the glucose transporter of Zymomonas mobilis leads to restoration of glucose and fructose uptake in Escherichia coli mutants and provides evidence for its facilitator action | Q39837166 | ||
Nargenicin attenuates lipopolysaccharide-induced inflammatory responses in BV-2 cells | Q39846327 | ||
Engineering yield and rate of reductive biotransformation in Escherichia coli by partial cyclization of the pentose phosphate pathway and PTS-independent glucose transport. | Q40961968 | ||
Successive nonstatistical and statistical approaches for the improved antibiotic activity of rare actinomycete Nonomuraea sp. JAJ18. | Q41808946 | ||
An insight into the "-omics" based engineering of streptomycetes for secondary metabolite overproduction | Q42181821 | ||
Re-engineering of genetic circuit for 2-deoxystreptamine (2-DOS) biosynthesis in Escherichia coli BL21 (DE3). | Q43498892 | ||
Phosphoenolpyruvate availability and the biosynthesis of shikimic acid | Q44468174 | ||
Biosynthesis of pyrrolylpolyenes in Auxarthron umbrinum. | Q46198902 | ||
Enhancement of UDPG synthetic pathway improves ansamitocin production in Actinosynnem pretiosum. | Q50910710 | ||
Analysis of intracellular short organic acid-coenzyme A esters from actinomycetes using liquid chromatography-electrospray ionization-mass spectrometry. | Q53568509 | ||
ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli. | Q54311805 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | synthetic biology | Q862838 |
P304 | page(s) | 9917-9931 | |
P577 | publication date | 2016-07-14 | |
P1433 | published in | Applied Microbiology and Biotechnology | Q13553694 |
P1476 | title | Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform | |
P478 | volume | 100 |
Q38406021 | Actinomadura Species: Laboratory Maintenance and Ribosome Engineering |
Q33634190 | Coalition of Biology and Chemistry for Ameliorating Antimicrobial Drug Discovery |
Q61446947 | Combinatorial approach for improved cyanidin 3-O-glucoside production in Escherichia coli |
Q92599386 | Engineering actinomycetes for biosynthesis of macrolactone polyketides |
Q88801399 | Improved production of 1-deoxynojirymicin in Escherichia coli through metabolic engineering |
Q33799744 | Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds. |
Q38719554 | Microbial production of astilbin, a bioactive rhamnosylated flavanonol, from taxifolin. |
Q61798192 | Production of a Novel Tetrahydroxynaphthalene (THN) Derivative from sp. CS682 by Metabolic Engineering and Its Bioactivities |
Q50281299 | Rewriting the Metabolic Blueprint: Advances in Pathway Diversification in Microorganisms |
Q38406026 | Saccharopolyspora Species: Laboratory Maintenance and Enhanced Production of Secondary Metabolites. |
Search more.